Skip Over Navigation Links
National Institutes of Health
:
Find more NIMH pages about: Schizophrenia

Science News about Schizophrenia

Find Press Releases and Science Updates by Topic

Health Risks Associated with Certain Antipsychotics Warrant Extra Monitoring
July 24, 2008 • Science Update
Some atypical antipsychotics may be more likely than others to cause metabolic and cardiovascular side effects, according to recent analyses using data from the NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).
Newer Antipsychotics No Better Than Older Medications in Reducing Schizophrenia-related Violence
July 11, 2008 • Science Update
Antipsychotic medications can reduce the risk of violence among people with schizophrenia, but the newer atypical antipsychotics are no more effective in doing so than older medications.
Abnormal Surge in Brain Development Occurs in Teens and Young Adults with Schizophrenia
July 8, 2008 • Science Update
Schizophrenia may occur, in part, because brain development goes awry during adolescence and young adulthood, when the brain is eliminating some connections between cells as a normal part of maturation, results of a study suggest. The new report appears online July 8, 2008 in Molecular Psychiatry.
NIMH Schizophrenia Initiative Featured in Biological Psychiatry
July 3, 2008 • Science Update
An NIMH initiative to fill the gap between advances in basic cognitive neuroscience and practical clinical applications for patients with schizophrenia is the topic of the July 1, 2008 issue of Biological Psychiatry. It contains eight articles on the Cognitive Neuroscience Approaches to the Treatment of Impaired Cognition in Schizophrenia (CNTRICS) initiative, including a commentary, and descriptions of meetings related to the effort.
Mice Expressing Human Genes Bred to Help Unravel Mental Disorders
June 26, 2008 • Science Update
New mouse strains engineered to express human genes related to mental disorders are being developed under a recently-launched grant program from NIMH's Division of Neuroscience and Basic Behavioral Science.
Study launched to test possible preventive treatment for schizophrenia in high risk youth
May 1, 2008 • Science Update
NIMH recently awarded a grant to study whether an intensive, computerized training program can help prevent youth at high risk for developing schizophrenia from having a first psychotic episode and improve adaptive functioning.
Rates of Rare Mutations Soar Three to Four Times Higher in Schizophrenia
March 27, 2008 • Press Release
People with schizophrenia have high rates of rare genetic deletions and duplications that likely disrupt the developing brain, according to studies funded in part by the National Institutes of Health.
Scans Reveal Faulty Brain Wiring Caused by Missing Genes
February 20, 2008 • Science Update
An NIMH study using an emerging imaging technology has discovered faulty wiring in the brains of people with Williams Syndrome, a rare genetic disorder that affects some aspects of thinking.
Tomorrow’s Antidepressants: Skip the Serotonin Boost?
February 14, 2008 • Science Update
Even when serotonin levels stayed low, scientists were able to correct abnormal, mental-illness-like behaviors in mice by blocking an enzyme called GSK3ß. The finding adds evidence that molecular targets other than serotonin may lead to better and faster medications for some mental illnesses.
Scientists Can Predict Psychotic Illness in up to 80 Percent of High-Risk Youth
January 7, 2008 • Press Release
Youth who are going to develop psychosis can be identified before their illness becomes full-blown 35 percent of the time if they meet widely accepted criteria for risk, but that figure rises to 65 to 80 percent if they have certain combinations of risk factors, the largest study of its kind has shown.
1 | 2 | 3 | 4 | 5 | Next >